Ciminelli is pleased to exclusively present the opportunity to acquire a free-standing, single-tenant dialysis facility leased to Fresenius Medical Care (“Fresenius”) with more than 10 years of remaining lease term. Fresenius has operated at this location since April 2017 and recently executed a new 10-year lease extension commencing April 1, 2027 and expiring March 31, 2037, demonstrating the tenant’s long-term commitment to the site and the mission-critical nature of the facility. The Property is offered with a modified net lease structure, providing investors with an attractive yield premium relative to traditional absolute net leased assets while maintaining the security of long-term occupancy by one of the world’s leading dialysis providers. About the Tenant Fresenius Medical Care (NYSE: FMS) is a global leader in dialysis services and products, operating approximately 3,675 clinics across more than 40 countries. Collectively, these facilities serve approximately 299,000 patients and provide nearly 48 million treatments annually. In the United States alone, Fresenius Kidney Care operates more than 2,200 dialysis centers serving approximately 200,000 patients, representing an estimated 37% share of the U.S. dialysis market.